ErbB2/Her2 Human anti-Human, DyLight 350, Clone: 4D5-8 (trastuzumab), Novus Biologicals
Human Monoclonal Antibody
Manufacturer: Novus Biologicals NBP275895UV
DescriptionErbB2/Her2 Monoclonal antibody specifically detects ErbB2/Her2 in Human samples. It is validated for Flow Cytometry, ELISA, Immunohistochemistry.
|Flow Cytometry, ELISA, Immunohistochemistry|
|A431 cells (human epidermoid carcinoma) (over)expressing EGFR.|
|Protein A purified|
|Breast Cancer, Cancer, Cellular Markers, Core ESC Like Genes, Oncogenes, Phospho Specific, Protein Kinase, Stem Cell Markers, Tumor Suppressors|
|ELISA, Flow Cytometry, Immunohistochemistry|
|50mM Sodium Borate with 0.05% Sodium Azide|
|CD340, CD340 antigen, c-erb B2/neu protein, EC 2.7.10, EGFR2, HER-2, HER2EC 22.214.171.124, herstatin, Metastatic lymph node gene 19 protein, MLN 19, MLN19, NEUHER-2/neu, neuroblastoma/glioblastoma derived oncogene homolog, NGLTKR1, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, receptor tyrosine-protein kinase erbB-2, Tyrosine kinase-type cell surface receptor HER2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian)|
|Store at 4°C in the dark.|
|Oncogenic protein Her-2/neu (erbB-2), a member of the family of epidermal growth factor (EGF) receptors, overexpressed in 30% of invasive breast cancers and 70% of ductal carcinomata in situ, in a small percentage of melanomas, and in other malignancies originating from various organs, including ovary, kidney, colon, and bladder.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok